Cellectis Announces Conference Call To Discuss UCART19 Development Collaboration With Pfizer And Servier

PARIS--(BUSINESS WIRE)--Regulatory News:

Cellectis (Alternext: ALCLS – Nasdaq: CLLS) will host a conference call with Pfizer Inc. (PFE) and Servier on Monday, December 7, 2015 at 8:00 a.m. Eastern Time to discuss their previously announced UCART19 development collaboration.